{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:10Z","timestamp":1787771410541,"version":"build-2784847793"},"reference-count":44,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Post Reprod Health"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Urogenital atrophy is more common than it would first appear and women do not always seek advice and guidance. Confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations but new treatment modalities have emerged that extend the range of options beyond lubricants, moisturisers and vaginal estrogen preparations.<\/jats:p>","DOI":"10.1177\/2053369118795349","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:25:31Z","timestamp":1537748731000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":21,"title":["BMS \u2013 Consensus statement"],"prefix":"10.1080","volume":"24","author":[{"given":"Joan","family":"Pitkin","sequence":"first","affiliation":[{"name":"Imperial College, Trustee BMS, Daisy Network, UK (previously Consultant Gynaecologist and Director of the Northwick Park Menopause Research and Clinical Unit, UK)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the British Menopause Society medical advisory council","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,9,23]]},"reference":[{"key":"bibr1-2053369118795349","volume":"15","author":"Levine KB","year":"2008","journal-title":"Menopause"},{"key":"bibr2-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1089\/152460900318830"},{"key":"bibr3-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03001-7"},{"key":"bibr4-2053369118795349","unstructured":"Banks J, Batty GD, Nazroo J, and Steptoe A. The dynamics of ageing: evidence from the English Longitudinal Study of Ageing 2002\u201315 (Wave 7). ESRC & IFS: London, 2016."},{"key":"bibr5-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(85)90057-X"},{"key":"bibr6-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004023"},{"key":"bibr7-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.23"},{"key":"bibr8-2053369118795349","first-page":"556","volume":"99","author":"Notelovitz M","year":"2002","journal-title":"Obstet Gynecol"},{"key":"bibr9-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2010.522875"},{"key":"bibr10-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000329"},{"key":"bibr11-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2000.00724.x"},{"key":"bibr12-2053369118795349","first-page":"1","volume":"157","author":"Smith P.","year":"1993","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"bibr13-2053369118795349","first-page":"655","volume":"39","author":"Zhu L","year":"2004","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"bibr14-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199004001-00006"},{"key":"bibr15-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1097\/01.GME.0000075502.60230.28"},{"key":"bibr16-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.1995.tb02099.x"},{"key":"bibr17-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(95)00955-8"},{"key":"bibr18-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/09513591003632258"},{"key":"bibr19-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1124259"},{"key":"bibr20-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199903000-00009"},{"key":"bibr21-2053369118795349","unstructured":"NICE Menopause guideline: diagnosis and management [NG23]. November 2015."},{"key":"bibr22-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001500.pub2"},{"key":"bibr23-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1080\/13697130802585576"},{"key":"bibr24-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2010.481058"},{"key":"bibr25-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(81)90041-4"},{"key":"bibr26-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000786"},{"key":"bibr27-2053369118795349","first-page":"722","volume":"92","author":"Cardozo L","year":"1998","journal-title":"Obstet Gynecol"},{"key":"bibr28-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1007\/s001920170088"},{"key":"bibr29-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2004.00581.x"},{"key":"bibr30-2053369118795349","unstructured":"Sant M, Galea P, Brincat MP. A comparative study between oestrogen replacement therapy, anticholinergic treatment and a combination of both in the management of detrusor instability in postmenopausal women. In:\n                      Book of Abstracts\n                      , The 10th World Congress on the menopause, Berlin 2002."},{"key":"bibr31-2053369118795349","unstructured":"NICE Urinary incontinence in women: management clinical guideline nice.org.uk\/guidance\/cg171 (2015)."},{"key":"bibr32-2053369118795349","unstructured":"Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994; 83(1): 12\u201318."},{"key":"bibr33-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/01443618909151046"},{"key":"bibr34-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2011.647840"},{"key":"bibr35-2053369118795349","doi-asserted-by":"crossref","unstructured":"Woyka J, Tanna N, Abernthy K, et\u00a0al.  A menopause service for women with breast cancer or at high risk from breast cancer. EJSO 2009;  35: 1226\u20131227.","DOI":"10.1016\/j.ejso.2009.07.094"},{"key":"bibr36-2053369118795349","doi-asserted-by":"crossref","unstructured":"Portman D, Palacios S, Nappi RE, et\u00a0al.  Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas 2014;  78: 91\u201398.","DOI":"10.1016\/j.maturitas.2014.02.015"},{"key":"bibr37-2053369118795349","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.954996"},{"key":"bibr38-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12377"},{"key":"bibr39-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6385"},{"key":"bibr40-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2017.07.003"},{"key":"bibr41-2053369118795349","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1436538"},{"key":"bibr42-2053369118795349","doi-asserted-by":"crossref","unstructured":"Mikic AN, et\u00a0al.  415 Use of vaginal erbium laser in treatment of vaginal relaxation syndrome and pelvic floor dysfunction. JISM 2017;  14: S126\u2013S127.","DOI":"10.1016\/j.jsxm.2016.11.293"},{"key":"bibr43-2053369118795349","doi-asserted-by":"crossref","unstructured":"Labrie F, Archer DF, Koltun W, et\u00a0al. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 2016;  23: 243\u2013256.","DOI":"10.1097\/GME.0000000000000571"},{"key":"bibr44-2053369118795349","doi-asserted-by":"crossref","unstructured":"Labrie F, Archer DF, Bouchard C, et\u00a0al.  Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas 2015; 81(1): 46\u201356.","DOI":"10.1016\/j.maturitas.2015.02.005"}],"container-title":["Post Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2053369118795349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2053369118795349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2053369118795349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:25:21Z","timestamp":1766517921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2053369118795349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1177\/2053369118795349"],"URL":"https:\/\/doi.org\/10.1177\/2053369118795349","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739487826.793582592","asserted-by":"object"}]},"ISSN":["2053-3691","2053-3705"],"issn-type":[{"value":"2053-3691","type":"print"},{"value":"2053-3705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}